The journey through moderate and advanced stages of dementia with Lewy bodies (DLB) — and through the end of life — remains one of the least understood parts of the disease, owing to a lack of research focused on later stages.

Most studies focus on earlier disease stages, when diagnosis is the central challenge. Far less is known about what drives symptom progression in later disease, what shapes quality of life for people living with DLB and their care partners as the disease advances, and how treatment strategies might be adapted to meet the distinctive needs of this group. A new study published in the journal Neurology takes an important step toward filling that gap — and in doing so, identifies a factor that may be influencing some of the most burdensome features of moderate to advanced DLB. Read the results. 🔗 in bio.